This protocol is judged by an institutional assessment board, an impartial group that critiques any clinical trials involving humans. If a analyze will involve a Schedule I drug, once the board approves the protocol as moral, the scientists really need to submit an application for an investigational new drug (IND) range through the FDA.Along with t